These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8236362)

  • 21. Some comments and suggestions concerning population pharmacokinetic modeling, especially of digoxin, and its relation to clinical therapy.
    Jelliffe RW
    Ther Drug Monit; 2012 Aug; 34(4):368-77. PubMed ID: 22735674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage.
    Bondareva IB; Jelliffe RW; Sokolov AV; Tischenkova IF
    J Clin Pharm Ther; 2004 Apr; 29(2):105-20. PubMed ID: 15068399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population pharmacokinetic parameters of vancomycin in critically ill patients.
    Llopis-Salvia P; Jiménez-Torres NV
    J Clin Pharm Ther; 2006 Oct; 31(5):447-54. PubMed ID: 16958822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population pharmacokinetic modelling of gentamicin and vancomycin in patients with unstable renal function following cardiothoracic surgery.
    Staatz CE; Byrne C; Thomson AH
    Br J Clin Pharmacol; 2006 Feb; 61(2):164-76. PubMed ID: 16433871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of a common spreadsheet program to demonstrate the ability of Bayesian forecasting to estimate the pharmacokinetic parameters of antibiotics.
    Brocks DR; Wang M
    J Pharm Pharmacol; 2023 Oct; 75(10):1378-1387. PubMed ID: 37478874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates.
    Lanao JM; Calvo MV; Mesa JA; Martín-Suárez A; Carbajosa MT; Miguelez F; Domínguez-Gil A
    J Antimicrob Chemother; 2004 Jul; 54(1):193-8. PubMed ID: 15150171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bayesian forecasting of gentamicin pharmacokinetics in pediatric intensive care unit patients.
    Kraus DM; Dusik CM; Rodvold KA; Campbell MM; Kecskes SA
    Pediatr Infect Dis J; 1993 Sep; 12(9):713-8. PubMed ID: 8414796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population pharmacokinetics of Rilpivirine in HIV-1-infected patients treated with the single-tablet regimen rilpivirine/tenofovir/emtricitabine.
    Néant N; Gattacceca F; Lê MP; Yazdanpanah Y; Dhiver C; Bregigeon S; Mokhtari S; Peytavin G; Tamalet C; Descamps D; Lacarelle B; Solas C
    Eur J Clin Pharmacol; 2018 Apr; 74(4):473-481. PubMed ID: 29374296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individualization of theophylline dosage: a Bayesian method evaluated in patients with once-daily dosing.
    Martz W; Oellerich M; Schnabel D; Sybrecht GW
    Ther Drug Monit; 1991 Sep; 13(5):420-4. PubMed ID: 1957334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population pharmacokinetic study of gentamicin and a Bayesian approach in patients with renal impairment.
    Lanao JM; Berrocal A; Calvo MV; Perez M; de la Calle B; Domínguez-Gil A
    J Clin Pharm Ther; 1989 Jun; 14(3):213-23. PubMed ID: 2760120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design.
    Leroux S; Turner MA; Guellec CB; Hill H; van den Anker JN; Kearns GL; Jacqz-Aigrain E; Zhao W;
    Clin Pharmacokinet; 2015 Dec; 54(12):1273-85. PubMed ID: 26063050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapeutic monitoring: analytic, pharmacokinetic and clinical aspects].
    Marquet P
    Acta Clin Belg; 1999; 53 Suppl 1():2-12. PubMed ID: 10216973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accuracy of Bayesian and Sawchuk-Zaske dosing methods for gentamicin.
    Burton ME; Chow MS; Platt DR; Day RB; Brater DC; Vasko MR
    Clin Pharm; 1986 Feb; 5(2):143-9. PubMed ID: 3754192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A priori prediction of gentamicin peak concentrations: Use of a simple and practical tool].
    Mignaval F; Fontaine PA; Riché A; Nowak C; Cancel D; Lemaitre F
    Pathol Biol (Paris); 2011 Apr; 59(2):79-82. PubMed ID: 20822863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug interaction studies with repaglinide: repaglinide on digoxin or theophylline pharmacokinetics and cimetidine on repaglinide pharmacokinetics.
    Hatorp V; Thomsen MS
    J Clin Pharmacol; 2000 Feb; 40(2):184-92. PubMed ID: 10664925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The accuracy of a pharmacokinetic theophylline predictor using once daily dosing.
    Chrystyn H; Mulley BA; Peake MD
    Br J Clin Pharmacol; 1987 Sep; 24(3):301-7. PubMed ID: 3663446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of steady-state plasma theophylline concentration by Bayesian algorithm.
    Imaeda N; Takagi K; Hasegawa T; Saito H; Mizukami Y
    Int J Clin Pharmacol Ther Toxicol; 1988 Dec; 26(12):588-93. PubMed ID: 3209276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of a quick modeling program generating clearance estimates at steady state for routine therapeutic drug monitoring.
    el Battah A; Beglia S; Alric R
    Ther Drug Monit; 1995 Aug; 17(4):348-55. PubMed ID: 7482688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Once-daily dosing of gentamicin: experience with therapeutic drug monitoring and Bayesian pharmacokinetics.
    Klotz U; Godel A
    Ther Drug Monit; 1994 Oct; 16(5):534-5. PubMed ID: 7846756
    [No Abstract]   [Full Text] [Related]  

  • 40. Bayesian parameter estimation and population pharmacokinetics.
    Thomson AH; Whiting B
    Clin Pharmacokinet; 1992 Jun; 22(6):447-67. PubMed ID: 1587057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.